DPN

(HB2489)

Certificate of Analysis

Latest Certificate of Analysis

Download the latest CoA for this product:

Download CoA

Download Batch-Specific CoA

To download the CoA for a batch, enter the batch ID below:

Technical documents: CoA SDS Datasheet

Product overview

Name DPN
Alternative names Diarylpropionitrile
Purity >98%
Description Selective ERβ estrogen receptor agonist
Write Your Own Review
You're reviewing:DPN
Rate this item:

Biological Data

Biological description Selective ERβ estrogen receptor agonist (Kd values are 5 and 400 nM at ERβ and ERα respectively). Shows 70-fold selectivity at ERβ over ERα. Shows neuroprotective effects. Active in vivo.

Solubility & Handling

Solubility overview Soluble in DMSO (100 mM) and in ethanol (100 mM)
Storage instructions -20°C (desiccate)
Storage of solutions Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use.
Shipping Conditions Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Purity >98%
Chemical name 2,3-bis(4-Hydroxyphenyl)-propionitrile
Molecular Weight 239.27
Chemical structure DPN [1428-67-7] Chemical Structure
Molecular Formula C15H13NO2
CAS Number 1428-67-7
PubChem identifier 102614
SMILES C1=CC(=CC=C1CC(C#N)C2=CC=C(C=C2)O)O
InChi InChI=1S/C15H13NO2/c16-10-13(12-3-7-15(18)8-4-12)9-11-1-5-14(17)6-2-11/h1-8,13,17-18H,9H2
InChiKey GHZHWDWADLAOIQ-UHFFFAOYSA-N
MDL number MFCD01695412

References for DPN

References are publications that support the biological activity of the product
  • Pharmacokinetics of the estrogen receptor subtype-selective ligands, PPT and DPN: quantification using UPLC-ES/MS/MS.

    Sepehr E et al (2012) J Pharm Biomed Anal 71 : 119-26.
  • The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease.

    Baraka AM et al (2011) Life Sci 88(19-20) : 879-85.
  • Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons.

    Zhao L et al (2004) Brain Res 1010(1-2) : 22-34.
  • Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.

    Meyers MJ et al (2001) J Med Chem 44(24) : 4230-51.

4 Item(s)